HTB

Pipeline report

Pipeline report 2021: HIV drugs in development

HIV pipeline 2020: new drugs in development – March 2020

HIV pipeline report 2019

Fit for purpose: Antiretroviral treatment optimisation July 2018

HIV pipeline 2018: full version

HIV pipeline report 2017

HIV pipeline 2017: full version

HIV pipeline 2017: summary version

HIV pipeline 2017: Update from IAS Paris

HIV pipeline 2017 PDFs

Fit for purpose (July 2017)

Acknowledgments

HTB supplement: 2016 Pipeline Report

Dedications

Executive summary – HIV

Executive summary – tuberculosis

The antiretroviral pipeline 2016

Fit for purpose: antiretroviral treatment optimisation 2016

The paediatric antiretroviral pipeline

Preventive technologies: antiretroviral and vaccine development

Research toward a cure and immune-based and gene therapies

The tuberculosis diagnostics pipeline

The tuberculosis prevention pipeline

The tuberculosis treatment pipeline: activity, but no answers

The paediatric tuberculosis treatment pipeline: beyond pharmacokinetics and safety data

2016 hepatitis C virus (HCV) update

HTB supplement: 2015 Pipeline Report

Dedication

The antiretroviral pipeline 2015

Fit for purpose: antiretroviral treatment optimisation 2015

The Pediatric Antiretroviral Pipeline

Preventive Technologies: Antiretroviral and Vaccine Development

Research Toward a Cure and Immune-Based and Gene Therapies

New Drugs, New Strategies: Conquering Hepatitis C with Direct-Acting Antivirals

The Tuberculosis Treatment Pipeline: Moving Beyond “Making the Most of What We’ve Got”

Momentum in the Pediatric Tuberculosis Treatment Pipeline

The Tuberculosis Diagnostics Pipeline

The Tuberculosis Vaccines Pipeline: A New Path to the Same Destination?

HTB supplement: 2014 Pipeline Report

Dedication: Marvin Oscar Shulman

Introduction and executive summary

The antiretroviral pipeline 2014

Fit for purpose: treatment optimisation 2014

The paediatric antiretroviral pipeline

Preventive technologies: antiretroviral and vaccine development

Research toward a cure and immune-based and gene therapies

Hepatitis C pipeline: BONANZA! The gold rush is under way

Global update: hepatitis C treatment activism

The tuberculosis diagnostics pipeline

Tuberculosis drug development hobbles forward

Playing catch-up: paediatric tuberculosis treatment pipeline

The tuberculosis vaccines pipeline

Acknowledgments

HTB supplement: 2013 pipeline report

Dedication: Spencer Cox

Seven ways to speed up the pipeline

Executive summary and research policy recommendations

The antiretroviral pipeline 2013

The paediatric antiretroviral pipeline

Retrofitting for purpose: treatment optimisation 2013

Preventive technologies, research toward a cure, and immune-based and gene therapies

Hepatitis C drug development catapults onward

Low- and middle-income countries defuse hepatitis C

The tuberculosis diagnostics pipeline

The tuberculosis treatment pipeline

Post navigation